Argent Biopharma Ltd (RGT.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 06-2020 | 06-2019 | 06-2018 | 06-2017 | 06-2016 | |
| Cash Flows From Operating Activities | |||||
| Operating Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -957 | -377 | -341 | -1,131 | -89 |
| Net Acquisitions | -13 | -1,140 | N/A | 0 | 143 |
| Purchase Sale Intangibles | N/A | N/A | N/A | N/A | -33 |
| Other Investing Activity | 0 | 570 | 0 | 500 | -672 |
| Investing Cash Flow | $-970 | $-947 | $-341 | $-631 | $-651 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 1,000 |
| Debt Repayment | N/A | N/A | N/A | -1,000 | -195 |
| Common Stock Issued | 11,433 | 36 | 5,017 | 10,533 | 11,125 |
| Common Stock Repurchased | -788 | -9 | -317 | -723 | -597 |
| Financing Cash Flow | $10,646 | $27 | $4,701 | $8,810 | $11,333 |
| Exchange Rate Effect | -16 | -231 | 22 | -54 | -3 |
| Beginning Cash Position | 2,354 | 9,859 | 11,364 | 7,896 | 437 |
| End Cash Position | 1,873 | 2,354 | 9,859 | 11,364 | 7,896 |
| Net Cash Flow | $-465 | $-7,274 | $-1,527 | $3,523 | $7,462 |
| Free Cash Flow | |||||
| Capital Expenditure | -962 | -362 | -459 | -631 | -281 |
| Free Cash Flow | -962 | -362 | -459 | -631 | -281 |